Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Non Operating Income (2016 - 2025)

iBio (IBIO) has disclosed Non Operating Income for 16 consecutive years, with $452000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 721.82% to $452000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $736000.0 through Dec 2025, down 44.49% year-over-year, with the annual reading at $225000.0 for FY2025, 81.11% down from the prior year.
  • Non Operating Income for Q4 2025 was $452000.0 at iBio, up from $231000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $9.6 million in Q2 2021, with the low at -$110000.0 in Q1 2023.
  • Average Non Operating Income over 5 years is $624526.3, with a median of $42000.0 recorded in 2022.
  • The sharpest move saw Non Operating Income surged 1663.5% in 2021, then crashed 361.9% in 2023.
  • Over 5 years, Non Operating Income stood at $40000.0 in 2021, then tumbled by 75.0% to $10000.0 in 2022, then dropped by 20.0% to $8000.0 in 2023, then skyrocketed by 587.5% to $55000.0 in 2024, then soared by 721.82% to $452000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $452000.0, $231000.0, and $35000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.